Thomas Morrison
Concepts (566)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chikungunya virus | 41 | 2026 | 81 | 14.650 |
Why?
| | Chikungunya Fever | 36 | 2026 | 82 | 11.210 |
Why?
| | Alphavirus Infections | 29 | 2024 | 45 | 7.870 |
Why?
| | Ross River virus | 19 | 2024 | 23 | 4.370 |
Why?
| | Viral Envelope Proteins | 14 | 2025 | 98 | 4.230 |
Why?
| | Virus Replication | 30 | 2026 | 519 | 3.510 |
Why?
| | Alphavirus | 12 | 2025 | 22 | 2.820 |
Why?
| | Antiviral Agents | 14 | 2025 | 767 | 2.310 |
Why?
| | Interferon Type I | 10 | 2024 | 147 | 2.110 |
Why?
| | Viremia | 5 | 2025 | 160 | 1.910 |
Why?
| | Host-Pathogen Interactions | 9 | 2021 | 361 | 1.860 |
Why?
| | Antibodies, Viral | 16 | 2025 | 673 | 1.840 |
Why?
| | Disease Models, Animal | 29 | 2026 | 4552 | 1.810 |
Why?
| | Joints | 5 | 2026 | 106 | 1.670 |
Why?
| | Animals | 104 | 2026 | 37952 | 1.580 |
Why?
| | Mice | 63 | 2026 | 18303 | 1.540 |
Why?
| | Antibodies, Neutralizing | 10 | 2025 | 340 | 1.530 |
Why?
| | Lymph Nodes | 5 | 2025 | 502 | 1.490 |
Why?
| | Virulence Factors | 5 | 2018 | 174 | 1.370 |
Why?
| | Receptors, Immunologic | 3 | 2023 | 208 | 1.360 |
Why?
| | Viral Nonstructural Proteins | 7 | 2025 | 63 | 1.310 |
Why?
| | Mice, Inbred C57BL | 32 | 2026 | 5972 | 1.240 |
Why?
| | Macrophages | 7 | 2026 | 1500 | 1.210 |
Why?
| | Adaptive Immunity | 5 | 2020 | 167 | 1.190 |
Why?
| | Viral Proteins | 12 | 2019 | 350 | 1.130 |
Why?
| | Newcastle disease virus | 13 | 2001 | 18 | 1.080 |
Why?
| | Viral Load | 11 | 2021 | 525 | 1.070 |
Why?
| | Encephalitis Virus, Venezuelan Equine | 4 | 2021 | 6 | 1.040 |
Why?
| | Viral Vaccines | 4 | 2022 | 107 | 1.030 |
Why?
| | Phagocytes | 2 | 2025 | 80 | 1.020 |
Why?
| | Monocytes | 4 | 2024 | 537 | 0.990 |
Why?
| | Viruses | 4 | 2022 | 164 | 0.980 |
Why?
| | Arthritis | 4 | 2020 | 96 | 0.960 |
Why?
| | Virulence | 11 | 2024 | 278 | 0.950 |
Why?
| | Arginase | 3 | 2015 | 26 | 0.940 |
Why?
| | CD8-Positive T-Lymphocytes | 8 | 2025 | 917 | 0.940 |
Why?
| | RNA, Viral | 15 | 2026 | 690 | 0.940 |
Why?
| | Encephalomyelitis, Equine | 1 | 2025 | 3 | 0.900 |
Why?
| | Encephalitis Virus, Eastern Equine | 1 | 2025 | 5 | 0.900 |
Why?
| | Clodronic Acid | 1 | 2025 | 19 | 0.870 |
Why?
| | B-Lymphocytes | 4 | 2020 | 866 | 0.860 |
Why?
| | Immune Evasion | 1 | 2025 | 61 | 0.850 |
Why?
| | 3' Untranslated Regions | 2 | 2024 | 149 | 0.810 |
Why?
| | Immunity, Innate | 7 | 2022 | 834 | 0.780 |
Why?
| | Interferon Regulatory Factors | 2 | 2022 | 44 | 0.780 |
Why?
| | Dendritic Cells | 4 | 2025 | 496 | 0.770 |
Why?
| | RNA Virus Infections | 3 | 2019 | 19 | 0.770 |
Why?
| | Kupffer Cells | 2 | 2021 | 52 | 0.770 |
Why?
| | Cell Line | 21 | 2024 | 2821 | 0.750 |
Why?
| | Virion | 3 | 2022 | 108 | 0.750 |
Why?
| | Liposomes | 1 | 2025 | 259 | 0.740 |
Why?
| | Musculoskeletal Diseases | 2 | 2016 | 90 | 0.730 |
Why?
| | Adaptor Proteins, Signal Transducing | 5 | 2021 | 425 | 0.710 |
Why?
| | Mice, Knockout | 18 | 2025 | 3114 | 0.700 |
Why?
| | Inflammation | 9 | 2023 | 2876 | 0.680 |
Why?
| | Neutrophils | 2 | 2020 | 1123 | 0.650 |
Why?
| | Viral Fusion Proteins | 8 | 2001 | 21 | 0.640 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2020 | 118 | 0.640 |
Why?
| | Chronic Disease | 5 | 2026 | 1806 | 0.640 |
Why?
| | Capsid Proteins | 3 | 2020 | 92 | 0.640 |
Why?
| | Homocystinuria | 1 | 2021 | 62 | 0.630 |
Why?
| | Myositis | 3 | 2012 | 57 | 0.620 |
Why?
| | NADPH Oxidase 2 | 1 | 2020 | 32 | 0.620 |
Why?
| | O'nyong-nyong Virus | 1 | 2019 | 4 | 0.610 |
Why?
| | Endothelial Cells | 6 | 2025 | 873 | 0.610 |
Why?
| | Myeloid Cells | 4 | 2024 | 146 | 0.610 |
Why?
| | Complement System Proteins | 4 | 2023 | 313 | 0.600 |
Why?
| | RNA Viruses | 2 | 2019 | 73 | 0.600 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2020 | 162 | 0.600 |
Why?
| | Herpesvirus 4, Human | 4 | 2004 | 172 | 0.600 |
Why?
| | Private Practice | 1 | 2019 | 17 | 0.590 |
Why?
| | Quinolones | 1 | 2021 | 203 | 0.570 |
Why?
| | Leishmania major | 1 | 2018 | 8 | 0.570 |
Why?
| | Students, Health Occupations | 1 | 2019 | 37 | 0.570 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 14 | 0.570 |
Why?
| | Preceptorship | 1 | 2019 | 63 | 0.560 |
Why?
| | Humans | 81 | 2025 | 145140 | 0.560 |
Why?
| | Vero Cells | 11 | 2024 | 83 | 0.560 |
Why?
| | Epitopes, T-Lymphocyte | 4 | 2024 | 174 | 0.540 |
Why?
| | Trans-Activators | 4 | 2004 | 396 | 0.540 |
Why?
| | Osteoarthritis | 1 | 2020 | 199 | 0.510 |
Why?
| | Occupational Therapy | 1 | 2019 | 109 | 0.510 |
Why?
| | Muscle, Skeletal | 9 | 2020 | 1789 | 0.510 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2017 | 7 | 0.510 |
Why?
| | Superoxide Dismutase | 1 | 2018 | 307 | 0.490 |
Why?
| | Mutation, Missense | 2 | 2019 | 335 | 0.480 |
Why?
| | Gene Deletion | 3 | 2018 | 391 | 0.480 |
Why?
| | Amino Acid Substitution | 3 | 2014 | 302 | 0.470 |
Why?
| | Immunization | 4 | 2024 | 375 | 0.470 |
Why?
| | Disease Outbreaks | 4 | 2023 | 419 | 0.460 |
Why?
| | Zika Virus | 1 | 2017 | 136 | 0.460 |
Why?
| | Epitopes | 3 | 2025 | 473 | 0.440 |
Why?
| | Lymphocytic choriomeningitis virus | 2 | 2025 | 36 | 0.440 |
Why?
| | Zika Virus Infection | 1 | 2017 | 172 | 0.430 |
Why?
| | Complement Activation | 5 | 2018 | 399 | 0.420 |
Why?
| | Tyrosine | 3 | 2013 | 217 | 0.390 |
Why?
| | Antigen Presentation | 2 | 2024 | 207 | 0.390 |
Why?
| | Membrane Fusion | 3 | 2001 | 41 | 0.390 |
Why?
| | Arthralgia | 1 | 2013 | 61 | 0.380 |
Why?
| | Histidine | 1 | 2013 | 66 | 0.380 |
Why?
| | Immunity, Cellular | 1 | 2014 | 273 | 0.380 |
Why?
| | Immunoglobulin G | 5 | 2024 | 887 | 0.360 |
Why?
| | Killer Cells, Natural | 4 | 2025 | 478 | 0.360 |
Why?
| | Sindbis Virus | 4 | 2017 | 10 | 0.350 |
Why?
| | Antibodies, Monoclonal | 5 | 2024 | 1505 | 0.350 |
Why?
| | DNA-Binding Proteins | 3 | 2004 | 1479 | 0.350 |
Why?
| | Severe Acute Respiratory Syndrome | 4 | 2018 | 19 | 0.350 |
Why?
| | Signal Transduction | 11 | 2024 | 5208 | 0.350 |
Why?
| | Tenosynovitis | 1 | 2010 | 11 | 0.330 |
Why?
| | Lung | 8 | 2025 | 4101 | 0.330 |
Why?
| | Emergency Responders | 2 | 2021 | 37 | 0.320 |
Why?
| | CD4-Positive T-Lymphocytes | 4 | 2026 | 1138 | 0.320 |
Why?
| | Up-Regulation | 1 | 2012 | 846 | 0.300 |
Why?
| | Mice, Transgenic | 4 | 2021 | 2185 | 0.290 |
Why?
| | HN Protein | 3 | 1993 | 5 | 0.290 |
Why?
| | Macrophage-1 Antigen | 1 | 2008 | 26 | 0.280 |
Why?
| | Lymphoid Tissue | 2 | 2019 | 77 | 0.280 |
Why?
| | Virus Diseases | 1 | 2011 | 216 | 0.280 |
Why?
| | T-Lymphocytes | 2 | 2019 | 1993 | 0.270 |
Why?
| | Spike Glycoprotein, Coronavirus | 4 | 2022 | 129 | 0.270 |
Why?
| | Mutation | 7 | 2025 | 4071 | 0.270 |
Why?
| | Arboviruses | 1 | 2008 | 14 | 0.270 |
Why?
| | Phenylalanine | 2 | 2022 | 69 | 0.270 |
Why?
| | Binding Sites | 4 | 2025 | 1309 | 0.270 |
Why?
| | Cell Membrane | 4 | 2018 | 707 | 0.270 |
Why?
| | Arbovirus Infections | 1 | 2008 | 20 | 0.270 |
Why?
| | Complement C3 | 4 | 2018 | 185 | 0.260 |
Why?
| | Cricetinae | 6 | 2020 | 302 | 0.260 |
Why?
| | Adoptive Transfer | 2 | 2020 | 199 | 0.260 |
Why?
| | Mutagenesis, Site-Directed | 7 | 2010 | 376 | 0.260 |
Why?
| | Amino Acids | 2 | 2025 | 519 | 0.260 |
Why?
| | Adenoviridae | 2 | 2021 | 199 | 0.260 |
Why?
| | Female | 24 | 2026 | 78636 | 0.240 |
Why?
| | Orthomyxoviridae Infections | 2 | 2025 | 71 | 0.230 |
Why?
| | West Nile virus | 2 | 2016 | 41 | 0.230 |
Why?
| | Lymphocyte Activation | 3 | 2025 | 1131 | 0.230 |
Why?
| | Phosphoproteins | 3 | 2016 | 337 | 0.230 |
Why?
| | Fibroblasts | 2 | 2024 | 1022 | 0.230 |
Why?
| | Enzyme Inhibitors | 3 | 2025 | 820 | 0.230 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2025 | 25 | 0.230 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2025 | 40 | 0.230 |
Why?
| | RNA Helicases | 1 | 2025 | 27 | 0.220 |
Why?
| | Cysteine Proteases | 1 | 2025 | 8 | 0.220 |
Why?
| | Cytokines | 5 | 2020 | 2048 | 0.220 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2025 | 49 | 0.220 |
Why?
| | Molecular Probes | 1 | 2025 | 33 | 0.220 |
Why?
| | Orthobunyavirus | 1 | 2025 | 8 | 0.220 |
Why?
| | Mice, Inbred BALB C | 4 | 2018 | 1261 | 0.220 |
Why?
| | Down-Regulation | 2 | 2004 | 618 | 0.220 |
Why?
| | Bunyaviridae Infections | 1 | 2025 | 15 | 0.220 |
Why?
| | Arthritis, Infectious | 1 | 2006 | 75 | 0.210 |
Why?
| | Microscopic Polyangiitis | 1 | 2024 | 13 | 0.210 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2024 | 33 | 0.210 |
Why?
| | Macaca mulatta | 2 | 2023 | 186 | 0.210 |
Why?
| | Uridine | 1 | 2024 | 30 | 0.210 |
Why?
| | Amides | 1 | 2024 | 101 | 0.210 |
Why?
| | Thiazoles | 1 | 2024 | 140 | 0.200 |
Why?
| | Peroxidase | 1 | 2024 | 168 | 0.200 |
Why?
| | Immunoassay | 2 | 2021 | 109 | 0.200 |
Why?
| | Sequence Deletion | 1 | 2024 | 190 | 0.200 |
Why?
| | Genetic Fitness | 1 | 2024 | 56 | 0.200 |
Why?
| | Antigens | 1 | 2025 | 348 | 0.200 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2023 | 35 | 0.200 |
Why?
| | Membrane Proteins | 2 | 2022 | 1163 | 0.200 |
Why?
| | Australia | 2 | 2022 | 287 | 0.200 |
Why?
| | NADPH Oxidases | 1 | 2024 | 122 | 0.200 |
Why?
| | Cell Proliferation | 3 | 2025 | 2504 | 0.200 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2004 | 161 | 0.190 |
Why?
| | Methionine | 1 | 2024 | 161 | 0.190 |
Why?
| | Genome, Viral | 4 | 2019 | 214 | 0.190 |
Why?
| | Ovalbumin | 2 | 2024 | 194 | 0.190 |
Why?
| | Structure-Activity Relationship | 5 | 2025 | 563 | 0.180 |
Why?
| | Antigens, Viral | 2 | 2021 | 182 | 0.180 |
Why?
| | Robotics | 1 | 2023 | 90 | 0.180 |
Why?
| | Single-Cell Analysis | 2 | 2025 | 361 | 0.180 |
Why?
| | Salmonella | 1 | 2022 | 47 | 0.180 |
Why?
| | NF-kappa B | 2 | 2008 | 664 | 0.180 |
Why?
| | Computational Biology | 2 | 2025 | 669 | 0.170 |
Why?
| | Base Sequence | 9 | 2010 | 2168 | 0.170 |
Why?
| | Transcriptional Activation | 2 | 2022 | 372 | 0.170 |
Why?
| | Arthritis, Rheumatoid | 1 | 2010 | 1174 | 0.170 |
Why?
| | Vaccines, Attenuated | 1 | 2022 | 129 | 0.170 |
Why?
| | Benzene Derivatives | 1 | 2021 | 7 | 0.170 |
Why?
| | Gynecology | 1 | 2023 | 181 | 0.170 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 302 | 0.170 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2004 | 431 | 0.170 |
Why?
| | Interferon-gamma | 3 | 2010 | 784 | 0.170 |
Why?
| | Robotic Surgical Procedures | 1 | 2023 | 183 | 0.170 |
Why?
| | Protein Biosynthesis | 4 | 2019 | 451 | 0.170 |
Why?
| | Convalescence | 1 | 2021 | 19 | 0.170 |
Why?
| | Nucleic Acid Conformation | 1 | 2024 | 723 | 0.170 |
Why?
| | Lung Neoplasms | 2 | 2025 | 2662 | 0.160 |
Why?
| | Oligosaccharides | 1 | 2001 | 60 | 0.160 |
Why?
| | Cystathionine beta-Synthase | 1 | 2021 | 65 | 0.160 |
Why?
| | Receptors, Mitogen | 1 | 2020 | 7 | 0.160 |
Why?
| | Oocytes | 2 | 2004 | 185 | 0.160 |
Why?
| | Protein Domains | 1 | 2022 | 311 | 0.160 |
Why?
| | Xenopus | 1 | 2000 | 87 | 0.160 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2001 | 101 | 0.160 |
Why?
| | Culicidae | 2 | 2013 | 33 | 0.160 |
Why?
| | Type C Phospholipases | 1 | 2000 | 69 | 0.160 |
Why?
| | Horses | 1 | 2021 | 224 | 0.160 |
Why?
| | Lectins, C-Type | 1 | 2020 | 59 | 0.160 |
Why?
| | Proteome | 1 | 2025 | 512 | 0.160 |
Why?
| | Specimen Handling | 1 | 2022 | 182 | 0.160 |
Why?
| | Influenza, Human | 2 | 2020 | 624 | 0.160 |
Why?
| | Interferon Regulatory Factor-3 | 2 | 2017 | 16 | 0.150 |
Why?
| | RNA, Messenger | 4 | 2020 | 2803 | 0.150 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2019 | 23 | 0.150 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2022 | 337 | 0.150 |
Why?
| | Glycoproteins | 2 | 2016 | 354 | 0.150 |
Why?
| | Encephalomyelitis, Venezuelan Equine | 1 | 2019 | 1 | 0.150 |
Why?
| | STAT1 Transcription Factor | 2 | 2010 | 66 | 0.150 |
Why?
| | Blotting, Western | 3 | 2015 | 1177 | 0.150 |
Why?
| | Benzylamines | 1 | 2019 | 44 | 0.150 |
Why?
| | Transfection | 7 | 2014 | 926 | 0.150 |
Why?
| | Molecular Sequence Data | 7 | 2010 | 2881 | 0.150 |
Why?
| | RNA, Double-Stranded | 1 | 2019 | 51 | 0.150 |
Why?
| | Primates | 2 | 2017 | 133 | 0.150 |
Why?
| | Blood Donors | 1 | 2021 | 144 | 0.150 |
Why?
| | Homeodomain Proteins | 3 | 2014 | 522 | 0.140 |
Why?
| | Laparoscopy | 1 | 2023 | 481 | 0.140 |
Why?
| | Parasite Load | 1 | 2018 | 10 | 0.140 |
Why?
| | Viral Tropism | 2 | 2019 | 36 | 0.140 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2020 | 199 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2004 | 1216 | 0.140 |
Why?
| | Leishmania donovani | 1 | 2018 | 12 | 0.140 |
Why?
| | Progesterone | 1 | 2000 | 214 | 0.140 |
Why?
| | Venules | 1 | 2018 | 14 | 0.140 |
Why?
| | Chemokine CCL21 | 1 | 2018 | 13 | 0.140 |
Why?
| | Endothelium, Lymphatic | 1 | 2018 | 11 | 0.140 |
Why?
| | Genes, Viral | 5 | 2006 | 88 | 0.140 |
Why?
| | src-Family Kinases | 1 | 2019 | 92 | 0.140 |
Why?
| | Problem-Based Learning | 1 | 2019 | 97 | 0.140 |
Why?
| | Interferon Regulatory Factor-7 | 1 | 2017 | 6 | 0.140 |
Why?
| | Peptides | 1 | 2024 | 997 | 0.130 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2017 | 16 | 0.130 |
Why?
| | Hindlimb | 2 | 2010 | 132 | 0.130 |
Why?
| | Antigens, Ly | 1 | 2017 | 42 | 0.130 |
Why?
| | Stromal Cells | 1 | 2018 | 120 | 0.130 |
Why?
| | Breast Neoplasms | 2 | 2025 | 2380 | 0.130 |
Why?
| | Receptors, CCR2 | 1 | 2017 | 38 | 0.130 |
Why?
| | Aedes | 2 | 2019 | 66 | 0.130 |
Why?
| | Canada | 1 | 2019 | 429 | 0.130 |
Why?
| | Methotrexate | 1 | 2019 | 233 | 0.130 |
Why?
| | Gene Expression | 4 | 2015 | 1474 | 0.130 |
Why?
| | Diphtheria Toxin | 1 | 2017 | 65 | 0.130 |
Why?
| | Drug Resistance, Viral | 3 | 2025 | 124 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2020 | 252 | 0.130 |
Why?
| | Polysaccharides | 1 | 2018 | 86 | 0.130 |
Why?
| | Oxidative Stress | 2 | 2022 | 1351 | 0.130 |
Why?
| | Lysine | 1 | 2019 | 304 | 0.130 |
Why?
| | Cell Survival | 4 | 2025 | 1100 | 0.130 |
Why?
| | HeLa Cells | 5 | 2023 | 631 | 0.130 |
Why?
| | Protein Processing, Post-Translational | 4 | 2012 | 469 | 0.130 |
Why?
| | Mutant Proteins | 2 | 2014 | 105 | 0.130 |
Why?
| | Mannose-Binding Lectin | 2 | 2018 | 20 | 0.120 |
Why?
| | Toll-Like Receptors | 1 | 2017 | 193 | 0.120 |
Why?
| | Patient Satisfaction | 1 | 2021 | 708 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 447 | 0.120 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 530 | 0.120 |
Why?
| | Antirheumatic Agents | 1 | 2019 | 307 | 0.120 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2016 | 55 | 0.120 |
Why?
| | Cytoplasm | 2 | 2017 | 254 | 0.120 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 243 | 0.120 |
Why?
| | Schistosomiasis mansoni | 1 | 2015 | 25 | 0.120 |
Why?
| | Schistosoma mansoni | 1 | 2015 | 41 | 0.110 |
Why?
| | alpha-Synuclein | 1 | 2015 | 45 | 0.110 |
Why?
| | Male | 13 | 2024 | 72664 | 0.110 |
Why?
| | Bacterial Proteins | 1 | 2022 | 962 | 0.110 |
Why?
| | RNA Caps | 1 | 2015 | 32 | 0.110 |
Why?
| | Histocompatibility Antigen H-2D | 1 | 2014 | 20 | 0.110 |
Why?
| | Epidemiological Monitoring | 1 | 2015 | 69 | 0.110 |
Why?
| | Communicable Disease Control | 1 | 2015 | 85 | 0.110 |
Why?
| | Friend murine leukemia virus | 1 | 2015 | 31 | 0.110 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2015 | 127 | 0.110 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2015 | 41 | 0.110 |
Why?
| | Cytidine Deaminase | 1 | 2015 | 59 | 0.110 |
Why?
| | Vaccination | 2 | 2021 | 1423 | 0.110 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2014 | 17 | 0.100 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2014 | 22 | 0.100 |
Why?
| | Pentose Phosphate Pathway | 1 | 2014 | 55 | 0.100 |
Why?
| | Animal Structures | 1 | 2014 | 10 | 0.100 |
Why?
| | Lymphangioleiomyomatosis | 1 | 2014 | 37 | 0.100 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2012 | 93 | 0.100 |
Why?
| | Flow Cytometry | 2 | 2015 | 1159 | 0.100 |
Why?
| | Glycosaminoglycans | 1 | 2013 | 79 | 0.100 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 172 | 0.090 |
Why?
| | Pandemics | 3 | 2023 | 1703 | 0.090 |
Why?
| | Arthritis, Experimental | 1 | 2014 | 136 | 0.090 |
Why?
| | Interleukin-6 | 2 | 2025 | 775 | 0.090 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 407 | 0.090 |
Why?
| | ELAV Proteins | 1 | 2012 | 14 | 0.090 |
Why?
| | Amino Acid Sequence | 6 | 1994 | 2127 | 0.090 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 1039 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 979 | 0.090 |
Why?
| | Carrier Proteins | 1 | 2016 | 728 | 0.090 |
Why?
| | Arthritis, Reactive | 1 | 2012 | 7 | 0.090 |
Why?
| | Mycobacterium tuberculosis | 1 | 2015 | 318 | 0.090 |
Why?
| | Caregivers | 1 | 2021 | 1070 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 440 | 0.090 |
Why?
| | Hospitalization | 1 | 2022 | 2458 | 0.090 |
Why?
| | Mosquito Vectors | 2 | 2024 | 31 | 0.090 |
Why?
| | Synovial Fluid | 2 | 2012 | 67 | 0.080 |
Why?
| | Influenza A Virus, H5N1 Subtype | 1 | 2011 | 10 | 0.080 |
Why?
| | Newcastle Disease | 1 | 1990 | 1 | 0.080 |
Why?
| | Avian Leukosis Virus | 1 | 1990 | 6 | 0.080 |
Why?
| | Reassortant Viruses | 1 | 2010 | 8 | 0.080 |
Why?
| | Protective Agents | 1 | 2011 | 42 | 0.080 |
Why?
| | Seroepidemiologic Studies | 2 | 2021 | 171 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 454 | 0.080 |
Why?
| | Time Factors | 3 | 2021 | 7107 | 0.080 |
Why?
| | Estradiol | 1 | 2014 | 512 | 0.080 |
Why?
| | Transcription, Genetic | 3 | 2004 | 1454 | 0.080 |
Why?
| | Chickens | 1 | 1990 | 179 | 0.080 |
Why?
| | DNA, Viral | 5 | 1993 | 355 | 0.080 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 2377 | 0.080 |
Why?
| | Receptors, Interferon | 1 | 2010 | 60 | 0.080 |
Why?
| | COS Cells | 2 | 2001 | 177 | 0.070 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 159 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2009 | 17 | 0.070 |
Why?
| | Genetic Vectors | 3 | 2021 | 335 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2009 | 33 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 80 | 0.070 |
Why?
| | Immunotherapy | 1 | 2014 | 665 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2021 | 6435 | 0.070 |
Why?
| | Calgranulin B | 1 | 2008 | 10 | 0.070 |
Why?
| | Flavivirus Infections | 1 | 2008 | 9 | 0.070 |
Why?
| | Flavivirus | 1 | 2008 | 19 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 847 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5886 | 0.060 |
Why?
| | Cricetulus | 3 | 2014 | 118 | 0.060 |
Why?
| | RNA, Small Interfering | 3 | 2020 | 634 | 0.060 |
Why?
| | Histocytochemistry | 1 | 2007 | 78 | 0.060 |
Why?
| | Gene Expression Profiling | 3 | 2025 | 1763 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2009 | 1244 | 0.060 |
Why?
| | Small Molecule Libraries | 2 | 2019 | 111 | 0.060 |
Why?
| | Serum | 1 | 2007 | 58 | 0.060 |
Why?
| | Cells, Cultured | 4 | 2020 | 4142 | 0.060 |
Why?
| | Insect Vectors | 1 | 2006 | 39 | 0.060 |
Why?
| | Sequence Alignment | 2 | 2025 | 362 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 6055 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2136 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2014 | 762 | 0.060 |
Why?
| | Reactive Oxygen Species | 2 | 2022 | 611 | 0.060 |
Why?
| | RNA Interference | 2 | 2020 | 474 | 0.060 |
Why?
| | Models, Molecular | 2 | 2025 | 1597 | 0.060 |
Why?
| | Mitochondrial Proteins | 1 | 2008 | 263 | 0.060 |
Why?
| | Glycosylation | 2 | 2006 | 173 | 0.060 |
Why?
| | Semliki forest virus | 1 | 2024 | 2 | 0.060 |
Why?
| | Organ Specificity | 1 | 2006 | 308 | 0.060 |
Why?
| | Cysteine Endopeptidases | 1 | 2025 | 74 | 0.050 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2004 | 50 | 0.050 |
Why?
| | Phosphorylation | 4 | 2012 | 1706 | 0.050 |
Why?
| | Chick Embryo | 4 | 1992 | 132 | 0.050 |
Why?
| | Drug Discovery | 1 | 2025 | 153 | 0.050 |
Why?
| | I-kappa B Proteins | 1 | 2004 | 75 | 0.050 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2004 | 117 | 0.050 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2004 | 132 | 0.050 |
Why?
| | Genes, Immediate-Early | 1 | 2004 | 26 | 0.050 |
Why?
| | Churg-Strauss Syndrome | 1 | 2024 | 27 | 0.050 |
Why?
| | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2024 | 24 | 0.050 |
Why?
| | Transcription Factor RelA | 1 | 2004 | 86 | 0.050 |
Why?
| | Sulfones | 1 | 2025 | 127 | 0.050 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2024 | 47 | 0.050 |
Why?
| | Immediate-Early Proteins | 1 | 2004 | 46 | 0.050 |
Why?
| | Glomerulonephritis | 1 | 2024 | 44 | 0.050 |
Why?
| | Plasmids | 3 | 1991 | 373 | 0.050 |
Why?
| | CHO Cells | 2 | 2014 | 169 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2024 | 65 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2019 | 740 | 0.050 |
Why?
| | Cell Line, Transformed | 1 | 2004 | 138 | 0.050 |
Why?
| | Centrifugation, Density Gradient | 2 | 2001 | 36 | 0.050 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2023 | 56 | 0.050 |
Why?
| | Cloning, Molecular | 3 | 2008 | 537 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2023 | 112 | 0.050 |
Why?
| | Brain | 1 | 2015 | 2934 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 206 | 0.050 |
Why?
| | Bone and Bones | 1 | 2006 | 317 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2004 | 167 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2009 | 666 | 0.050 |
Why?
| | Coculture Techniques | 1 | 2023 | 247 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 688 | 0.050 |
Why?
| | Body Weight | 1 | 2007 | 969 | 0.050 |
Why?
| | Keratinocytes | 1 | 2004 | 249 | 0.050 |
Why?
| | Epithelium | 1 | 2023 | 310 | 0.050 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2023 | 189 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2023 | 118 | 0.040 |
Why?
| | Salmonella typhimurium | 1 | 2024 | 188 | 0.040 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2022 | 62 | 0.040 |
Why?
| | Basal Ganglia Diseases | 1 | 2001 | 9 | 0.040 |
Why?
| | World Health Organization | 1 | 2022 | 104 | 0.040 |
Why?
| | Survival Analysis | 2 | 2015 | 1371 | 0.040 |
Why?
| | Central Nervous System Vascular Malformations | 1 | 2001 | 27 | 0.040 |
Why?
| | Cross Protection | 1 | 2021 | 5 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2004 | 587 | 0.040 |
Why?
| | Cross Reactions | 1 | 2021 | 130 | 0.040 |
Why?
| | Sulfonamides | 1 | 2025 | 583 | 0.040 |
Why?
| | Computer Simulation | 1 | 2025 | 1002 | 0.040 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2021 | 27 | 0.040 |
Why?
| | Microsomes, Liver | 1 | 2021 | 85 | 0.040 |
Why?
| | Half-Life | 1 | 2021 | 153 | 0.040 |
Why?
| | Mitochondria | 1 | 2008 | 992 | 0.040 |
Why?
| | Microspheres | 1 | 2021 | 141 | 0.040 |
Why?
| | Immunity | 1 | 2001 | 140 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 119 | 0.040 |
Why?
| | Child | 1 | 2021 | 22670 | 0.040 |
Why?
| | Colorado | 2 | 2021 | 4538 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2004 | 961 | 0.040 |
Why?
| | Genetic Engineering | 1 | 2021 | 88 | 0.040 |
Why?
| | Giant Cells | 2 | 1998 | 21 | 0.040 |
Why?
| | Tyrphostins | 1 | 2000 | 18 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2022 | 265 | 0.040 |
Why?
| | Phosphotyrosine | 1 | 2000 | 38 | 0.040 |
Why?
| | Metformin | 1 | 2004 | 327 | 0.040 |
Why?
| | Phosphoserine | 1 | 2000 | 25 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2001 | 365 | 0.040 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2020 | 42 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2008 | 2928 | 0.040 |
Why?
| | Kinetics | 2 | 2013 | 1567 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2000 | 153 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2019 | 146 | 0.040 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2023 | 532 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3539 | 0.040 |
Why?
| | Cell Adhesion Molecules | 1 | 2020 | 181 | 0.040 |
Why?
| | Transcriptome | 1 | 2025 | 1029 | 0.040 |
Why?
| | Cadherins | 1 | 2020 | 200 | 0.040 |
Why?
| | Protein Transport | 2 | 2012 | 441 | 0.040 |
Why?
| | Poly I-C | 1 | 2018 | 58 | 0.030 |
Why?
| | Interferon-beta | 2 | 2009 | 92 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 482 | 0.030 |
Why?
| | Trypsin | 1 | 1998 | 75 | 0.030 |
Why?
| | Autocrine Communication | 1 | 2018 | 38 | 0.030 |
Why?
| | Molecular Structure | 1 | 2019 | 486 | 0.030 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2018 | 45 | 0.030 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2018 | 35 | 0.030 |
Why?
| | Chemokines | 1 | 2018 | 217 | 0.030 |
Why?
| | Paracrine Communication | 1 | 2018 | 67 | 0.030 |
Why?
| | Spleen | 1 | 2019 | 507 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2019 | 175 | 0.030 |
Why?
| | Antigens, CD | 1 | 2020 | 558 | 0.030 |
Why?
| | Ischemia | 1 | 2020 | 422 | 0.030 |
Why?
| | Eukaryotic Initiation Factors | 1 | 2016 | 12 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2019 | 382 | 0.030 |
Why?
| | Capsid | 1 | 2017 | 93 | 0.030 |
Why?
| | Biological Transport | 3 | 1992 | 423 | 0.030 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2016 | 36 | 0.030 |
Why?
| | Virus Assembly | 1 | 2017 | 81 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2588 | 0.030 |
Why?
| | Ouabain | 1 | 2016 | 18 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1995 | 0.030 |
Why?
| | Atherosclerosis | 1 | 2020 | 409 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2020 | 379 | 0.030 |
Why?
| | Digoxin | 1 | 2016 | 27 | 0.030 |
Why?
| | Length of Stay | 1 | 2022 | 1348 | 0.030 |
Why?
| | Transcription Factors | 1 | 2004 | 1731 | 0.030 |
Why?
| | Monensin | 2 | 1985 | 2 | 0.030 |
Why?
| | Carbonyl Cyanide m-Chlorophenyl Hydrazone | 2 | 1985 | 4 | 0.030 |
Why?
| | Granuloma | 1 | 2015 | 97 | 0.030 |
Why?
| | Apoptosis | 1 | 2004 | 2434 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2026 | 0.030 |
Why?
| | Viral Plaque Assay | 2 | 1992 | 29 | 0.030 |
Why?
| | International Cooperation | 1 | 2015 | 197 | 0.030 |
Why?
| | Glucose Transporter Type 2 | 1 | 2014 | 16 | 0.030 |
Why?
| | NADP | 1 | 2014 | 52 | 0.030 |
Why?
| | Vesicular stomatitis Indiana virus | 1 | 1974 | 13 | 0.030 |
Why?
| | RNA Stability | 1 | 2015 | 107 | 0.030 |
Why?
| | Glucose Transporter Type 1 | 1 | 2014 | 48 | 0.030 |
Why?
| | Reticulocytes | 1 | 1974 | 17 | 0.030 |
Why?
| | Virus Attachment | 1 | 2013 | 19 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1189 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2014 | 132 | 0.030 |
Why?
| | Drug Implants | 1 | 2014 | 83 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1058 | 0.030 |
Why?
| | Precipitin Tests | 1 | 1993 | 90 | 0.020 |
Why?
| | Virus Internalization | 1 | 2013 | 65 | 0.020 |
Why?
| | Static Electricity | 1 | 2013 | 114 | 0.020 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2014 | 70 | 0.020 |
Why?
| | Hydrogen Bonding | 1 | 2013 | 169 | 0.020 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 138 | 0.020 |
Why?
| | Mice, SCID | 1 | 2014 | 369 | 0.020 |
Why?
| | Cell Fusion | 1 | 1993 | 48 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3410 | 0.020 |
Why?
| | Conserved Sequence | 1 | 1993 | 244 | 0.020 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1993 | 141 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2013 | 204 | 0.020 |
Why?
| | Endosomes | 1 | 2013 | 140 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 629 | 0.020 |
Why?
| | Protein Binding | 2 | 2009 | 2235 | 0.020 |
Why?
| | Alternative Splicing | 1 | 2014 | 247 | 0.020 |
Why?
| | Biomarkers | 1 | 2023 | 4282 | 0.020 |
Why?
| | Global Health | 1 | 2015 | 403 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 320 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 172 | 0.020 |
Why?
| | Caspases | 1 | 2012 | 233 | 0.020 |
Why?
| | Viral Structural Proteins | 1 | 1991 | 12 | 0.020 |
Why?
| | Poultry | 1 | 1990 | 9 | 0.020 |
Why?
| | Complement C5a | 1 | 2011 | 54 | 0.020 |
Why?
| | Prospective Studies | 1 | 2023 | 8035 | 0.020 |
Why?
| | Tritium | 2 | 1985 | 67 | 0.020 |
Why?
| | Orthomyxoviridae | 1 | 1991 | 40 | 0.020 |
Why?
| | DNA | 2 | 1988 | 1433 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 1985 | 331 | 0.020 |
Why?
| | Vaccines, Synthetic | 1 | 1990 | 137 | 0.020 |
Why?
| | Polyribosomes | 2 | 1984 | 22 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2010 | 318 | 0.020 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2009 | 35 | 0.020 |
Why?
| | Antibody Formation | 1 | 1990 | 287 | 0.020 |
Why?
| | Receptors, CCR | 1 | 2008 | 6 | 0.020 |
Why?
| | Insulin | 1 | 2000 | 2510 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2009 | 88 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 139 | 0.020 |
Why?
| | Virus Cultivation | 1 | 2008 | 31 | 0.020 |
Why?
| | Immunoblotting | 1 | 2009 | 295 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2001 | 3892 | 0.020 |
Why?
| | Glucose | 1 | 2014 | 1048 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 1844 | 0.020 |
Why?
| | Metabolomics | 1 | 2014 | 730 | 0.020 |
Why?
| | Oligonucleotides | 1 | 2009 | 153 | 0.020 |
Why?
| | Seasons | 1 | 2011 | 538 | 0.020 |
Why?
| | Middle Aged | 2 | 2021 | 36126 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 977 | 0.020 |
Why?
| | Genes | 1 | 1988 | 226 | 0.020 |
Why?
| | Mitochondrial Membranes | 1 | 2008 | 40 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2008 | 427 | 0.020 |
Why?
| | Protein Conformation | 2 | 1992 | 936 | 0.020 |
Why?
| | DNA, Recombinant | 1 | 1986 | 48 | 0.020 |
Why?
| | Neurons | 1 | 2015 | 1644 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10857 | 0.020 |
Why?
| | Nucleic Acid Hybridization | 1 | 1986 | 187 | 0.010 |
Why?
| | Mercaptoethanol | 1 | 1985 | 8 | 0.010 |
Why?
| | Rats | 1 | 2014 | 5582 | 0.010 |
Why?
| | Disulfides | 1 | 1985 | 94 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2006 | 128 | 0.010 |
Why?
| | Fucose | 1 | 1985 | 7 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2023 | 17247 | 0.010 |
Why?
| | Immune System | 1 | 2006 | 177 | 0.010 |
Why?
| | Poly A | 1 | 1984 | 50 | 0.010 |
Why?
| | Xenopus laevis | 1 | 2004 | 104 | 0.010 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2004 | 44 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2004 | 54 | 0.010 |
Why?
| | Receptor, Insulin | 1 | 2004 | 93 | 0.010 |
Why?
| | Response Elements | 1 | 2004 | 86 | 0.010 |
Why?
| | RNA | 1 | 2010 | 910 | 0.010 |
Why?
| | Models, Genetic | 1 | 2006 | 523 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 855 | 0.010 |
Why?
| | Basal Ganglia | 1 | 2001 | 57 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2004 | 1368 | 0.010 |
Why?
| | Adult | 2 | 2021 | 40665 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2004 | 1393 | 0.010 |
Why?
| | Carcinoma, Krebs 2 | 1 | 1974 | 1 | 0.010 |
Why?
| | Electrophoresis, Paper | 1 | 1974 | 1 | 0.010 |
Why?
| | Chromatography, Paper | 1 | 1974 | 3 | 0.010 |
Why?
| | Sulfur Radioisotopes | 1 | 1974 | 13 | 0.010 |
Why?
| | Carbon Radioisotopes | 1 | 1974 | 29 | 0.010 |
Why?
| | Peptide Biosynthesis | 1 | 1974 | 13 | 0.010 |
Why?
| | Tissue Extracts | 1 | 1974 | 19 | 0.010 |
Why?
| | Hydroxyapatites | 1 | 1974 | 16 | 0.010 |
Why?
| | Chromatography | 1 | 1974 | 27 | 0.010 |
Why?
| | Autoradiography | 1 | 1974 | 66 | 0.010 |
Why?
| | Cell-Free System | 1 | 1974 | 53 | 0.010 |
Why?
| | Triticum | 1 | 1974 | 18 | 0.010 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 1974 | 41 | 0.010 |
Why?
| | Rabbits | 1 | 1974 | 652 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 1992 | 72 | 0.010 |
Why?
| | Viral Matrix Proteins | 1 | 1992 | 28 | 0.010 |
Why?
|
|
Morrison's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|